☰

Tao Liu - Publications

Affiliations: 
2014- School of Chemistry and Environment Beihang University 
Area:
OPV
Tree Info Grants Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tsai C, Zhao R, Moore R, Williams S, Schultz K, Piehowski P, Pasa-Tolic L, Rodland K, Smith R, Shi T, Zhu Y, Liu T. Abstract 2856: An intelligent boosting to amplify signal with isobaric labeling (iBASIL) strategy for precise quantitative single-cell proteomics analysis Cancer Research. 80: 2856-2856. DOI: 10.1158/1538-7445.Am2020-2856  0.301
2019 Nagy Z, Kanikevich M, Koach J, Mayoh C, Carter D, Liu T, Du Y, Jiang C, Haber M, Norris M, Cheung B, Marshall G. Abstract 3659: Alyref is a novel binding partner and co-factor for MYCN-driven oncogenesis in neuroblastoma Cancer Research. 79: 3659-3659. DOI: 10.1158/1538-7445.Am2019-3659  0.313
2018 Zhang P, Gaffrey MJ, Zhu Y, Chrisler WB, Fillmore TL, Yi L, Nicora CD, Zhang T, Wu H, Jacobs JM, Tang K, Kagan J, Srivastava S, Rodland KD, Qian WJ, ... Liu T, et al. Carrier-assisted single-tube processing approach for targeted proteomics analysis of low numbers of mammalian cells. Analytical Chemistry. PMID 30557009 DOI: 10.1021/Acs.Analchem.8B04258  0.308
2016 Xue C, Yu DM, Gherardi S, Koach J, Milazzo G, Gamble L, Liu B, Russell A, Liu T, Cheung BB, Marshall GM, Perini G, Haber M, Norris MD. Abstract 2450: MYCN and TFAP4 promote neuroblastoma malignancy by cooperating in the regulation a subset of target genes involved in cancer cell growth and metastasis Cancer Research. 76: 2450-2450. DOI: 10.1158/1538-7445.Am2016-2450  0.304
2015 Koach J, Liu B, Bell JL, Hüttelmaier S, Liu T, Carter DR, Haber M, Norris MD, Fletcher J, Cheung BB, Marshall GM. Abstract 962: PA2G4 predicts poor prognosis in neuroblastoma patients and promotes neuroblastoma progression by enhancing MYCN protein stability Cancer Research. 75: 962-962. DOI: 10.1158/1538-7445.Am2015-962  0.306
2014 Shi T, He J, Wu C, Fillmore TL, Schepmoes AA, Rubin M, Siddiqui J, Wei J, Chinnaiyan A, Liu A, Smith RD, Kagan J, Srivastava S, Rodland KD, Qian W, Liu T, et al. Abstract 2483: An antibody-independent, complementary SRM strategy for ultrasensitive and multiplexed quantification of cancer biomarker candidates Cancer Research. 74: 2483-2483. DOI: 10.1158/1538-7445.Am2014-2483  0.302
Show low-probability matches.